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Summary
CD18 integrins promote neutrophil recruitment, and
their engagement activates tyrosine kinases, leading
to neutrophil activation. However, the significance of
integrin-dependent leukocyte activation in vivo has
been difficult to prove. Here, in a model of thrombohe-
morrhagic vasculitis, the CD18 integrin Mac-1 on neu-
trophils recognized complement C3 deposited within
vessel walls and triggered a signaling pathway involv-
ing the Src-family kinase Hck and the Syk tyrosine ki-
nase. This led to neutrophil elastase release, causing
hemorrhage, fibrin deposition, and thrombosis. Mice
genetically deficient in any of these components (C3,
Mac-1, Hck, Syk, or elastase) were resistant to disease
despite normal tissue neutrophil accumulation. Dis-
ease was restored in Mac-1-deficient mice infused
with wild-type, but not kinase- or elastase-deficient,
neutrophils. Elastase release in the inflamed tissue
was reduced in Mac-1-deficient mice, and a deficiency
of Mac-1 or the kinases blocked neutrophil elastase re-
lease in vitro. These data suggest that Mac-1 engage-
ment of complement activates tyrosine kinases to pro-
mote elastase-dependent blood vessel injury in vivo.
Introduction
Neutrophils are key players of the innate immune re-
sponse during both host defense and inflammation.
Neutrophil functions are largely dependent on the leuko-
cyte-specific CD18 integrins. In vivo, blockade or a defi-
ciency of CD18 integrins limits inflammation, primarily
by reducing neutrophil recruitment to the site of injury.
In vitro, engagement of CD18 integrins signals activation
of effector functions (ROS production and degranula-
tion) (Harris et al., 2000). However, despite the clear
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6 These authors contributed equally to this work.evidence that neutrophil integrin signaling in vitro leads
to cellular activation, it remains unclear to what extent
this contributes to tissue injury or host defense in vivo.
Indeed, in immune complex-mediated inflammatory dis-
eases, it is often assumed that signaling through neutro-
phil Fc receptors is primarily responsible for activation
of cellular effector function, while the integrins serve
mainly a supporting role to facilitate cellular recruitment.
Given the complexity of most disease models, where
infiltrating inflammatory cells are receiving signals
through numerous ligands, it is often difficult to sort
out the relative contribution of integrins alone to neutro-
phil activation in vivo. Thus, defining a model of an in-
flammatory disease that is strictly dependent on integrin
signaling of neutrophil effector functions remains an
elusive goal in the field of inflammation research.
The CD18 integrins LFA-1 (CD11a/CD18, aLb2), Mac-1
(CD11b/CD18, amb2, CR3), p150,95 (CD11c/CD18, acb2),
and CD11d/CD18 (adb2) are composed of unique CD11
subunits complexed to a common CD18 subunit. Pa-
tients with a deficiency in the CD18 subunit have in-
creased susceptibility to bacterial and fungal infections,
which is associated with the inability of their neutrophils
and macrophages to migrate and perform cytotoxic
functions (Anderson and Springer, 1987). In mice, a defi-
ciency in CD18 or a CD18 receptor intercellular adhesion
molecule 1 (ICAM-1), present on the endothelium and
leukocytes, attenuates neutrophil accumulation and as-
sociated tissue injury in models of inflmmation (Harris
et al., 2000; Kakkar and Lefer, 2004). Studies in mice de-
ficient in LFA-1 suggest that it plays a dominant role in
neutrophil vascular arrest and transendothelial migra-
tion (Andrew et al., 1998; Ding et al., 1999; Henderson
et al., 2003). In contrast, Mac-1, which is the predomi-
nant CD18 integrin on neutrophils, is postulated to
play a more important role in activation of effector func-
tions (Coxon et al., 1996; Ding et al., 1999; Lu et al., 1997;
Mayadas and Cullere, 2005; Tang et al., 1997).
Mac-1-mediated adhesion to complement iC3b-
coated microbes promotes neutrophil phagocytosis
and the release of oxygen radicals and proteinases
within phagolysosomes, which is important for host de-
fense. However, when the opsonized target is too large
to ingest, the extracellular release of these products
may contribute to tissue injury during inflammation (Ar-
naout, 1990; Ross, 2000). In vitro studies have delin-
eated signaling cascades responsible for CD18 integ-
rin-mediated adhesion, degranulation, and reactive
oxygen species (ROS) generation (Lowell, 2004; Lowell
and Berton, 1999). Integrin engagement results in acti-
vation of Src-family and Syk tyrosine kinases, which co-
localize with CD18 integrins to phosphorylate a number
of downstream targets including Cbl, Pyk-2, PLCg1 and
2, ERK, Vav, and Paxillin. Of these substrates, Cbl, SLP-
76, and Vav 1,3 have been demonstrated to play a role in
neutrophil and macrophage integrin signaling in vitro
(Caveggion et al., 2003; Gakidis et al., 2004; Newbrough
et al., 2003). In vitro neutrophils deficient in Src-family
members Hck and Fgr have defects in adhesion-depen-
dent secondary granule release (Mocsai et al., 1999) and
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duced ROS generation and secondary granule release
(Mocsai et al., 2002).
Neutrophil-derived cytotoxic products play an impor-
tant role in the inflammation of the vessel wall. The local
Shwartzman-like reaction (LSR), induced by repeated
cytokine injection in the skin, produces histopathologic
lesions that are characteristic of thrombohemorrhagic
vasculitis (Brozna, 1990) and resemble those observed
in SLE in cases where vascular damage occurs in the
presence of complement deposition (Danning et al.,
1998; Philips et al., 1989; Riemekasten et al., 2002).
The LSR is dependent on neutrophils (Argenbright and
Barton, 1992; Chang et al., 1993; Stetson and Good,
1951; Zhou et al., 2003). Neutrophil aggregation, their
interaction with the endothelium and platelets as well
as neutrophil-derived microparticles promote the gen-
eration of occlusive thrombi, fibrin accumulation, and
hemorrhage (Bouchard and Tracy, 2001; Brozna, 1990;
Gasser and Schifferli, 2005).
In this work, we directly tested the contribution of
Mac-1, its ligands, effector mechanisms, and signaling
pathways to the LSR by using relevant gene mutant
mice and intravenous reconstitution of mice with puri-
fied neutrophils. While Mac-1-deficient mice showed
normal infiltration of neutrophils into the inflammatory
site, these mice failed to develop significant hemor-
rhagic vasculitis, thus separating the neutrophil recruit-
ment versus activation functions of this leukocyte integ-
rin. Mac-1 engagement of complement within the vessel
wall signaled activation of Src-family and Syk kinases
in a signaling pathway that led to neutrophil elastase
release, which in turn was responsible for blood vessel
injury. These data delineate an important physiological
role for Mac-1-mediated signaling of effector functions
in tissue damage associated with thrombohemorrhagic
vasculitis.
Results
Mac-1 Is Required for the Formation of Hemorrhagic
Lesions
The local Shwartzman reaction (LSR) was elicited by an
initial intradermal injection of lipopolysaccharide (LPS)
followed 20–24 hr later by a challenge with tumor necro-
sis factor (TNF) at the same site. 24 hr after TNF injec-
tion, hemorrhaging was observed in the intact skin.
Microscopic analysis of skin tissue sections revealed
significant erythrocyte extravasation, neutrophil accu-
mulation, extravascular fibrin accumulation, and occlu-
sive thrombi containing neutrophils. Mac-1-deficient
mice subjected to LSR exhibited no detectable hemor-
rhage (Figure 1). This was associated with a substantial
decrease in the number of thrombus-occluded vessels
and reduced fibrin deposition. The fibrin that was pres-
ent formed a ring within the lumen of intact vessels in
contrast to the predominantly extravascular fibrin accu-
mulation observed in wild-type mice. Despite the ab-
sence of hemorrhage in Mac-1-deficient mice, neutro-
phil accumulation in the skin lesions of the mutant
mice was essentially equivalent to that of wild-type ani-
mals as assessed on tissue sections (Figure 1A). Inter-
estingly, neutrophils adherent to the vessel wall of
wild-type animals tended to be flattened against thelumen while those in the Mac-1-deficient animals were
round in appearance (Figure 1B, c and d), perhaps re-
flecting altered adhesion-dependent spreading of the
Mac-1-deficient cells. Tissue neutrophil accumulation
as assayed by tissue myeloperoxidase (MPO) activity
(converted to number of neutrophils via a standard
curve) was shown to be comparable in both groups of
animals (#neutrophils 3 104/mg tissue: wt, 2.13 6 0.17;
Mac-1-deficient, 2.02 6 0.16). Neutrophil accumulation
was also similar in wild-type and Mac-1-deficient mice
after LPS injection alone or LPS followed by a 4 hr TNF
stimulation (data not shown). These data indicate that
in the LSR model, the CD18 integrin Mac-1 is not critical
for neutrophil recruitment to the inflammatory site but is
required for tissue injury leading to the development of
thrombohemorrhagic vasculitis.
The LSR was evaluated in LFA-1-deficient mice to as-
sess the relative contribution of this sister CD18 integrin
in neutrophil accumulation and tissue injury. LFA-1-defi-
cient mice exhibited only a 20% reduction in hemor-
rhage (RBC as % of tissue area: wt, 11.7 6 0.32; LFA-
1-deficient, 9.31 6 0.90, p < 0.05, n = 6 per group) and
a 12% reduction in neutrophil accumulation (data not
shown). We conclude that, in contrast to Mac-1, the
CD18 integrin LFA-1 does not play a major role in dis-
ease pathogenesis in the LSR model.
In vitro studies in macrophages suggest that LPS sig-
naling through CD14 requires Mac-1 (Dobrovolskaia and
Vogel, 2002). Ribonuclease protection analysis of total
RNA in skin-tissue samples of LPS-injected mice re-
vealed that cytokines upregulated by LPS (IL-1b, IL-1 re-
ceptor antagonist, and IL-6) were similar in wild-type
and Mac-1-deficient mice. Others, including IFNg, IL-12
(p35, p40), IL-18, MIF, and IL-1a, did not increase upon
LPS treatment in either genotype (Figure 1C, data not
shown), and the cytokine profile did not change upon
additional challenge with TNF (data not shown). Thus,
the phenotype in Mac-1-deficient mice in LSR is likely
not the result of altered cytokine production after LPS
injection.
Mac-1 on Intravascular Neutrophils Promotes
Hemorrhagic Lesions
Mac-1 is present on murine neutrophils, eosinophils,
mast cells, monocytes, and tissue macrophages. To ex-
amine whether Mac-1 on neutrophils is responsible for
hemorrhagic lesions, Mac-1-deficient mice were in-
jected intravenously with purified bone marrow-derived
neutrophils harvested from wild-type or Mac-1-deficient
mice 2 hr prior to TNF injection in the dorsal skin to in-
duce the LSR. The adoptive transfer of wild-type neutro-
phils into Mac-1-deficient mice restored the formation
of hemorrhagic lesions while the transfer of Mac-1-defi-
cient cells had no effect despite robust neutrophil re-
cruitment to the site of inflammation (Figure 2). The
extent of hemorrhage, thrombus formation, and fibrin
deposition was essentially the same in Mac-1-deficient
mice injected with wild-type neutrophils as seen in nor-
mal wild-type animals. In contrast to intravenous trans-
fers, injection of wild-type neutrophils intradermally (at
the site of LPS and TNF injection) into Mac-1-deficient
animals was not effective in reconstituting disease
(data not shown). Therefore, Mac-1 on intravascular
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273Figure 1. Mac-1-Deficient Mice Fail to Develop Thrombohemorrha-
gic Vasculitis in the Local Shwartzman-like Reaction Despite Normal
Neutrophil Recruitment and Production of Inflammatory Cytokines
(A) Wild-type (wt) and Mac-1-deficient (Mac-12/2) mice were sub-
jected to the LSR, and lesions in sections of harvested skin were
scored. The percent of tissue area of extravascular RBCs and neu-
trophils in four low-power fields (403 objective) for hemorrhage
and neutrophil (Neut.) exudates, respectively, was determined in
wt and Mac-12/2 mice. The percent of vessels with fibrin staining
outside the vessel wall and the percent of vessels occluded by
thrombus were quantitated by scoring all morphologically intact
vessels in the skin sample. In parentheses are the numbers of
mice of each genotype analyzed to produce the shown averaged
data 6 SEM, *p < 0.05.
(B) Representative skin sections from wild-type (a, c) and Mac-12/2
(b, d) mice are shown. (a and b) Hematoxylin and eosin-stained sec-
tions show hemorrhaging and thrombosis in wild-type mice with the
strongest reaction evident in the deep dermis just above the panni-
culus carnosus muscle (*). This reaction was not present inMac-12/2
mice. An arrow identifies a blood vessel in each section (c and d). A
specific esterase stain revealed neutrophils (small blue cells, arrow)
adherent to the vessel wall and in the extravascular space of wild-neutrophils is an important determinant of the thrombo-
hemorrhagic pathology.
Role for Mac-1 Ligand Complement C3 but Not
ICAM-1 in Thrombohemorrhagic Lesions
Mac-1 recognizes several ligands including ICAM-1,
complement fragment iC3b (generated by complement
C3 activation), GpIb on platelets, and coagulation fac-
tors fibrinogen and factor X (Arnaout, 1990; Mayadas
and Cullere, 2005). Here, we examined whether Mac-1
ligands ICAM-1 and complement fragment iC3b were
required for the development of thrombohemorrhagic
lesions by analyzing LSR in mice deficient in ICAM-1
or complement C3 (C32/2). ICAM-1-deficient mice had
normal neutrophil accumulation with lesion scores that
were similar to their wild-type counterparts (Table 1).
In contrast, C32/2 animals exhibited no hemorrhaging
or microthrombi and markedly reduced fibrin deposition
despite normal neutrophil accumulation (Table 1). Ad-
herent neutrophils within vessels of C32/2 mice ex-
hibited a round morphology, similar to that seen in
Mac-1-deficient animals (data not shown). Thus, C3
deficiency recapitulated the phenotype observed in
Mac-1-deficient mice.
The distribution of complement C3 deposition in the
LSR lesions was examined by immunohistochemistry.
Significant C3 deposition was observed along the vessel
walls at sites of inflammation (Figure 3). Importantly, the
extent of C3 deposition was similar in wild-type and
Mac-1-deficient animals. No C3 staining was observed
in dorsal skin injected with PBS alone (Figure 3). To-
gether these data suggest that complement C3 is acti-
vated and deposits in the vessel wall upon induction of
the LSR and that Mac-1-mediated neutrophil interaction
with C3 results in vessel injury and leakage leading to
thrombohemorrhagic lesions. However, neither C3 nor
Mac-1 played a significant role in neutrophil recruitment
to the inflammatory sites during the LSR.
Role of NADPH Oxidase-Generated Reactive Oxygen
Species and Proteinases in Shwartzman Reaction
Neutrophil degranulation results in the surface transloca-
tion and/or release of proteinases (Owen and Campbell,
1999) as well as the production of NADPH oxidase-
derived oxygen radicals, both of which are potential me-
diators of vessel injury. To elucidate the role of various
proteinases versus oxygen radicals in the development
of vascular lesion during the LSR, we examined mice
lacking the serine proteinase neutrophil elastase (NE),
metalloproteinases MMP8 or MMP9 alone or both
type and Mac-12/2 mice. The larger blue cell (arrowhead in [d]) is
a mast cell that also stains positively with the esterase stain and is
excluded from the quantitative analysis. Note the flattened appear-
ance of intravascular neutrophils in sections from wild-type (c) com-
pared to the rounded neutrophils in Mac-12/2 (d) mice identified by
arrows. Scale bar equals 100 mm, double scale bar equals 20 mm.
(C) Total RNA was prepared from skin samples harvested from the
LSR site of wild-type and Mac-1-deficient mice. RNA for indicated
cytokines and housekeeping genes, L32 and GADPH, was detected
in a multiprobe ribonuclease protection assay. A representative au-
toradiograph of samples from control wild-type (W) and Mac-1-defi-
cient (K) mice after PBS or LPS injection are shown. Cytokines that
were upregulated after LPS treatment are indicated by asterisks (*).
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gp91phox. The LSR was intact in gp91phox-deficient
(gp912/2) mice, suggesting that reactive oxygen spe-
cies do not play a major role in the development of
lesions or neutrophil accumulation (Table 2A). Interest-
ingly, hemorrhagic and fibrinous lesions were absent
in the NE-deficient mice, despite normal neutrophil ac-
cumulation (Table 2B), while none of these parameters
were altered in mice deficient in either MMP8 or MMP9
alone or in mice doubly deficient in both MMP8 and 9
(Table 2C). Thus, NE is one of the major proteinases
that mediate development of thrombohemorrhagic le-
sions in the LSR without altering cellular recruitment to
Figure 2. Adoptive Transfer of Wild-Type Neutrophils Restores
Thrombohemorrhagic Vasculitis in Mac-1-Deficient Mice
(A) Mac-1-deficient mice primed with LPS were injected once intra-
venously with 53 106 wild-type (wt/Mac-12/2) or Mac-1-deficient
neutrophils (Mac-12/2 / Mac-12/2) just prior to intradermal TNF
injection. Scoring of skin lesions in tissue sections for parameters
of hemorrhaging, thrombi, fibrin, and neutrophil accumulation was
conducted as described in Figure 1. Numbers in parentheses are
the number of mice used to produce the shown averaged data 6
SEM, *p < 0.05.
(B) Representative high-magnification images of hematoxylin and
eosin-stained sections of Mac-1-deficient mice injected with wild-
type (a) or Mac-1-deficient (b) neutrophils are shown. A vessel
from Mac-1-deficient animal injected with wild-type neutrophils ex-
hibits hemorrhage and a thrombus (white asterisk) and is distended
(a), while a vessel of Mac-1-deficient mouse injected with Mac-1-de-
ficient neutrophils shows significant intralumenal (white arrow) and
extravascular neutrophil accumulation but no hemorrhage or throm-
bus (b). Double scale bar equals 20 mm.the inflammatory site, a phenotype also seen in both
the C32/2 and Mac-1-deficient mice.
Mac-1-Mediated Vessel Injury Requires
Neutrophil Elastase
Neutrophil elastase was first identified in neutrophils but
is also present in small amounts in monocytes and mast
cells (Kawabata et al., 2002; Owen and Campbell, 1999).
To test whether elastase in neutrophils alone is responsi-
ble for lesion development, the LSR was evaluated in
Mac-1-deficient mice injected intravenously with either
elastase-deficient or wild-type neutrophils. Mac-1-defi-
cient mice injected with NE-deficient neutrophils ex-
hibited no indices of disease despite significant accumu-
lation of neutrophils at the inflammatory lesion site, while
Mac-1 null mice injected with wild-type cells exhibited
substantial lesion development (Figures 4A and 4B).
These crosscomplementation studies demonstrate that
elastase in neutrophils is required for the LSR and that
NE is a critical downstream mediator of Mac-1-dependent
thrombohemorrhagic lesion development in the LSR.
Next, we evaluated whether Mac-1 deficiency resulted
in a decrease in NE release in vivo in response to the LSR.
For this, the LSR was induced in an air pouch generated
in the dorsal skin of mice, and the air pouch was lavaged
to retrieve accumulated neutrophils and fluid. The la-
vage, as well as the intact neutrophils, were assayed
for elastase activity because a portion of the released
elastase binds to the surface of neutrophils (Owen
et al., 1995). The total number of cells in the lavage of
wild-type and Mac-1-deficient mice was similar (wt,
1.56 6 0.11 3 106; Mac-1-deficient, 1.39 6 0.04 3 106).
However, elastase release was reduced by approxi-
mately 75% in Mac-1-deficient compared to wild-type
samples (Figure 4C). These data demonstrate that
Mac-1 null neutrophils fail to release NE in vivo during
the Shwartzman reaction.
The Src-Family Kinases Are Required for
Thrombohemorrhagic Vasculitis:
A Dominant Role for Hck
The Src-family kinases in neutrophils, Hck, Fgr, and Lyn
play a primary role in integrin-signaling pathways. Defi-
ciency of both Hck and Fgr resulted in a defect in adhe-
sion-mediated activation downstream of b1, b2 (CD18),
and b3 integrins, whereas a deficiency in either alone
has no detectable phenotype (Lowell et al., 1996). Defi-
ciency in all three of these kinases results in an even
more profound defect in integrin signaling, while loss
of Lyn alone leads to a hyperresponsive adhesion phe-
notype—indicative of the dual role of Lyn kinase as
both a positive and negative regulator of intracellularTable 1. C3-Deficient Mice Fail to Develop Thrombohemorrhagic Vasculitis while ICAM-1-Deficient Animals Respond Normally in the Localized
Shwartzman Reaction
Grading (%) Wild-Type (n = 8) C32/2 (n = 10) Wild-Type (n = 4) ICAM-12/2 (n = 4)
Hemorrhage 5.98 6 2.22 0.00 6 0.00* 10.86 6 2.19 9.78 6 2.35
Fibrin 77.38 6 2.57 14.03 6 1.78* 79.75 6 4.14 81.70 6 9.09
Thrombi 78.59 6 2.92 20.44 6 2.61* 62.32 6 3.36 60.92 6 9.90
Neut. Exudate 11.06 6 2.31 10.37 6 2.03 12.35 6 1.32 13.48 6 1.25
Skin sections from LSR lesions in wild-type, C3-deficient (C32/2), or ICAM-1-deficient (ICAM-12/2) mice were prepared and scored as described
in Figure 1. n = number of mice of each genotype analyzed to produce the averaged data, *p < 0.05 compared to wild-type cohorts.
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To examine whether Src-family kinases are critical for
Mac-1-mediated signaling in vivo, we analyzed mice de-
ficient in Hck, Fgr, or Lyn alone as well as mice lacking all
three kinases in the LSR. Fgr2/2mice developed hemor-
rhagic lesions that were partially reduced compared to
wild-type animals while Lyn deficiency resulted in a fur-
ther modest reduction in disease indices (Figure 5A). In
both these kinase mutant strains, all animals showed
clear evidence of some hemorrhage after TNF injection.
In contrast, 73% of Hck2/2mice were completely free of
extravascular hemorrhage and fibrin deposition, with
the remaining animals displaying variable amounts of
disease formation. Triple src-deficient mice exhibited
no hemorrhage and significantly reduced fibrin deposi-
tion in response to the LSR (Figure 5A). These data indi-
cate that the Src-family kinases in myeloid leukocytes
have partially redundant roles in initiating thrombohe-
morrhagic vasculitis, with the Hck kinase playing the
most important function. Loss of Hck alone or deficiency
of all three kinases produced a profound impairment in
hemorrhage and fibrin formation in the LSR model, with-
out affecting neutrophil migration (Figure 5A), a pheno-
type very similar to that of the C3-, Mac-1-, or neutrophil
elastase-deficient mice.
Figure 3. Complement C3 Is Deposited along Vessel Walls during
Experimental Thrombohemorrhagic Vasculitis
Skin-tissue sections from wt (top) or Mac-1-deficient (middle) mice
subjected to the LSR and wt mice injected with PBS alone (bottom)
were stained with polyclonal anti-C3 antibody. C3 staining is ob-
served along a vessel (arrow) from a wild-type (top) and Mac-1-de-
ficient (middle) animal subjected to LSR, while no C3 staining is ob-
served in a vessel (arrowhead) of a wild-type mouse injected with
PBS alone (bottom). Complement C3-deficient mice subjected to
LSR showed no staining (not shown), demonstrating the specificity
of the C3 antibody.To evaluate whether the phenotypes observed in the
single and triple src mutant mice could be attributed to
the role of Src-family proteins specifically in neutrophils,
Mac-1-deficient mice were injected with neutrophils
from either Hck2/2, Fgr2/2, or triple src mutant mice
and examined in the LSR. Mac-1-deficient mice injected
with Hck2/2 neutrophils prior to initiation of the LSR
showed significantly reduced hemorrhage and modestly
reduced fibrin deposition compared to injection of wild-
type cells (Figures 5B and 5C). Adoptive transfer of triple
src mutant neutrophils into Mac-1-deficient mice failed
to reconstitute disease formation; the Mac-1-deficient
recipients in these experiments showed no evidence of
extravascular hemorrhage or fibrin deposition. Thus, re-
constitution of Mac-1 mutant mice with either Hck2/2 or
triple src-deficient neutrophils produces the same phe-
notypic response in the LSR as seen in the original kinase
mutant animals, indicating that loss of these kinases in
neutrophils alone is responsible for the amelioration of
inflammatory disease in this model. In contrast, Mac-1-
deficient mice that were injected with Fgr2/2 neutrophils
showed nearly normal levels of hemorrhage (Hemor-
rhage %: wt neutrophils, 12.58 6 0.39; Fgr2/2 neutro-
phils, 9.816 1.11, p = 0.40), which differed from the mod-
erate reduction in hemorrhage seen in the Fgr2/2 mice
alone. Thus, the loss of Fgr from cells other than neutro-
phils likely contributed to the partially reduced response
to the LSR observed in Fgr2/2 mice (Figure 5A).
To further validate that loss of Src-family kinases in
neutrophils alone is capable of blocking disease activity
in the LSR and that Mac-1 is upstream of these kinases,
we attempted to restore disease to triple src mutant
mice by injection of wild-type or Mac-1-deficient neutro-
phils. As expected, triple src mutant mice injected with
wild-type neutrophils displayed normal levels of hemor-
rhage and fibrin deposition after initiation of the LSR,
while triple src mutant mice injected with Mac-1-defi-
cient cells remained free of disease (Figures 5B and
5C). These crosscomplementation experiments confirm
that Src-family kinases in neutrophils are required for
thrombohemorrhagic vasculitis.
Syk Is Required for Mac-1-Dependent Vasculopathy
The described role for the Syk in outside-in integrin sig-
naling in neutrophils in vitro (Mocsai et al., 2002) promp-
ted us to determine whether this kinase is also required
for Mac-1-dependent thrombohemorrhagic vasculitis
in vivo. To examine this, chimeric mice were generated
by injecting fetal liver cells from Syk2/2mice into lethally
irradiated wild-type recipients, allowing us to circum-
vent the perinatal lethality caused by the Syk mutation
(Turner et al., 2000). Controls for these animals were irra-
diated wild-type mice injected with fetal liver cells from
wild-type or Syk+/2 animals. Surprisingly, even wild-
type mice reconstituted with wild-type cells after lethal
irradiation failed to develop reproducible evidence of
thrombohemorrhagic vasculitis in the LSR (data not
shown), precluding the examination of intact chimeras
in these experiments. Therefore, the role of Syk kinase
in neutrophils in the LSR was examined by attempting
to restore disease in Mac-1-deficient mice with neutro-
phils from wild-type and Syk2/2 fetal liver chimeric
mice. Mac-1-deficient mice injected with neutrophils
from wild-type or Syk+/2 fetal liver chimeric mice
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276Table 2. Neutrophil Elastase-Deficient Mice Fail to Develop Thrombohemorrhagic Vasculitis in the LSR, while Mice Deficient in NADPH Oxidase
Function or Lacking MMP8 and MMP9 Respond Normally
(A) Mice Lacking the gp91phox Subunit of the NADPH Oxidase (gp912/2)
Grading (%) Wild-Type (n = 10) gp912/2 (n = 10)
Hemorrhage 6.28 6 0.74 4.64 6 1.87
Fibrin 73.03 6 6.13 61.13 6 20.50
Thrombi 57.62 6 5.56 52.35 6 8.93
Neut. Exudate 9.84 6 1.13 7.15 6 1.29
(B) Mice Lacking the Primary Granule Proteinase Neutrophil Elastase (NE2/2)
Grading (%) Wild-Type (n = 6) NE2/2 (n = 5)
Hemorrhage 8.91 6 1.03 0.02 6 0.02*
Fibrin 83.40 6 0.32 34.50 6 12.18*
Thrombi 54.31 6 9.96 14.34 6 1.52*
Neut. Exudate 14.78 6 2.23 10.91 6 1.39
(C) Mice Lacking the Primary Granule Proteinases MMP8 and/or MMP9 (Single MMP82/2 or MMP92/2 Mutants or Double MMP8/MMP92/2
Mutants)
Grading (%) Wild-Type (n = 5) MMP92/2 (n = 3) Wild-Type (n = 8) MMP82/2 (n = 6)
Hemorrhage 12.44 6 3.54 14.47 6 6.91 9.66 6 1.04 10.59 6 2.34
Fibrin 75.30 6 3.36 74.90 6 14.13 81.47 6 2.41 76.65 6 3.35
Thrombi 55.50 6 9.18 61.30 6 21.55 71.17 6 2.84 68.25 6 4.80
Neut. Exudate 13.63 6 1.78 17.06 6 0.33 11.33 6 1.38 9.42 6 2.22
Grading (%) Wild-Type (n = 4) MMP8/MMP92/2 (n = 3)
Hemorrhage 9.46 6 1.66 12.12 6 1.71
Fibrin 77.65 6 3.38 77.56 6 4.52
Thrombi 66.01 6 4.25 74.14 6 5.96
Neut. Exudate 10.96 6 2.40 9.55 6 1.65
LSR lesions in wild-type and indicated deficient mice were assessed for hemorrhage, thrombi, fibrin deposition, and neutrophil accumulation as
described in Figure 1. n = number of mice of each genotype analyzed to produce the averaged data, *p < 0.05 compared to wild-type cohorts.developed hemorrhage and fibrin deposition in the LSR,
while Mac-1-deficient mice receiving Syk2/2 cells failed
to show evidence of disease (Table 3). As seen in the
C32/2, Mac-1-deficient, NE-deficient, and the Hck,Fgr,
Lyn2/2 triple knockout mice, Syk2/2 neutrophils were
recruited normally into the inflammatory site, indicating
that this kinase is not involved in neutrophil migration, as
previously reported in a thioglycollate-induced peritoni-
tis model (Mocsai et al., 2002). These results directly
implicate Syk kinase in neutrophils in the development
of Mac-1-mediated thrombohemorrhagic vasculitis at
a step involving neutrophil activation and elastase re-
lease, without altering neutrophil recruitment.
Mac-1 Adhesion-Dependent Release of Elastase In
Vitro Requires Complement C3 and Hck Kinase
Our in vivo results suggest that Mac-1-mediated adhe-
sion to complement results in elastase release that is
largely dependent on the Src-family kinase Hck. Previ-
ous reports have shown that adhesion of activated neu-
trophils to surfaces coated with integrin ligands (e.g.,
fibrinogen or collagen) results in the exocytosis of pri-
mary (azurophilic) and secondary (specific) granules
(Mocsai et al., 1999, 2002). We designed an in vitro assay
to assess the role of Src kinases in Mac-1-mediated ad-
hesion and release of elastase (present in primary gran-
ules) to complement-coated surfaces after TNF stimula-
tion. Since biomaterials such as tissue-culture plates are
well described to activate complement C3 resulting in
deposition of C3b and iC3b (Andersson et al., 2002; Che-
noweth et al., 1981), this assay presents high-density
Mac-1 ligands to the leukocyte, similar to the situationof vascular deposition of C3 components in the LSR.
The adhesion of TNF-stimulated wild-type neutrophils
to plates coated with freshly prepared mouse serum
was dependent on Mac-1 and complement, as shown
by the fact that both Mac-1-deficient neutrophils and
C32/2 serum failed to support significant neutrophil ad-
hesion (Figure 6A). To measure the adhesion-dependent
release of neutrophil elastase, we used a continuous
spectroscopic assay containing a fluorogenic substrate
specific for neutrophil elastase (Sklar et al., 1982). Adhe-
sion of wild-type neutrophils to complement-coated
plates resulted in significant elastase release, whereas
Mac-1-deficient neutrophils or wild-type neutrophils ad-
herent to plates coated with C32/2 serum exhibited sig-
nificantly less elastase release (Figure 6B). Similar to the
adhesion assay, primary granule release was very low
in Mac-1-deficient cells plated on C32/2 serum. Thus,
TNF-induced Mac-1 interaction with complement iC3b
is responsible for the majority (greater than 70%) of elas-
tase release observed in this assay.
The role of Src-family kinases in Mac-1 and C3 adhe-
sion-mediated elastase release was evaluated by as-
sessing degranulation in neutrophils deficient in the
Hck, Fgr, or Lyn kinases alone or all three src kinases.
As shown in Figure 6C, both the Hck2/2 and triple src
mutant cells manifested a large reduction in degranula-
tion after adhesion to wild-type serum-coated surfaces.
In contrast, Fgr2/2 and Lyn2/2 cells showed no signifi-
cant decrease in elastase release in this assay. These
in vitro elastase results correlate well with the in vivo
observations in the LSR and suggest that the Hck kinase
is the dominant neutrophil Src-family kinase involved
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surface bound complement.
Discussion
Our studies establish a key role for Mac-1 in the destruc-
tion of vascular integrity associated with a model of
thrombohemorrhagic vasculitis. These data are consis-
tent with previous reports showing inhibition of LSR
lesions after treatment with CD11b blocking antibody
(Argenbright and Barton, 1992; Chang et al., 1993). The
Figure 4. Adoptive Transfer of Elastase-Deficient Neutrophils Fails
to Restore Thrombohemorrhagic Vasculitis to Mac-1-Deficient Mice
(A) Mac-1-deficient (Mac-12/2) mice primed with LPS were injected
once intravenously with 5 3 106 wild-type (wt/ Mac-12/2) or neu-
trophil elastase-deficient (NE2/2 / Mac-12/2) cells just prior to
intradermal TNF injection, and lesions were scored as outlined in
Figure 1, Numbers in parentheses are the number of mice used to
produce the shown averaged data 6 SEM, *p < 0.05.
(B) Representative sections of Mac-1-deficient mice injected with
wild-type (a) or NE2/2 (b) neutrophils are shown. Mac-1-deficient
mice injected with wt cells exhibited significant hemorrhage, throm-
bus formation, and neutrophil infiltration (a), while those injected
with NE2/2 cells (b) displayed intense neutrophil infiltration at the
TNF injection site (white asterisk) without evidence of hemorrhage
or thrombus formation.
(C) Skin air pouches were generated in Mac-1-deficient (Mac-12/2)
and wild-type (wt) mice and the LSR was induced in this site. The
pouches were lavaged, and intact neutrophils and lavage fluid
were assayed for neutrophil elastase activity. The percent degranu-
lation was calculated by dividing the elastase activity by the total
cellular elastase activity measured after lysis of cells in the sample.
n = 4 for each genotype. Data shown are average 6 SD, *p < 0.05.near absence of tissue injury in Mac-1-deficient mice
was not the result of changes in cytokines induced dur-
ing the LSR (IL-6, IL-1b, IL-1ra), nor was it attributable to
reduced neutrophil accumulation in the skin. Thus the
LSR model allows us to separate the function of integrin
Figure 5. Lack of Src-Family Kinases in Neutrophils Renders Mice
Resistant to Experimental Thrombohemorrhagic Vasculitis
(A) Wild-type, Fgr2/2, Lyn2/2, Hck2/2, or triple src mutant (H,F,L2/2)
mice were subjected to the LSR, and scoring of tissue sections for
percent hemorrhage, extravascular fibrin deposition, and neutrophil
exudates was performed as in Figure 1.
(B) Mac-1-deficient mice primed with LPS were injected once intra-
venously with 5 3 106 wild-type (wt / Mac-12/2), single mutant
hck2/2 (Hck2/2 / Mac12/2), or triple src mutant (H,F,L2/2 /
Mac-12/2) neutrophils just prior to intradermal TNF injection, and
lesions were scored as outlined in Figure 1. In addition, H,F,L2/2
mutant mice served as recipients for injection of either wild-type
(wt / H,F,L2/2) or Mac-1-deficient (Mac-12/2 / H,F,L2/2) cells,
after which mice were analyzed in the LSR as above. Numbers in
parentheses indicate the number of animals of each genotype
analyzed to produce the shown averaged data 6 SEM. *p < 0.005,
**p < 0.05 in comparison to wild-type.
(C) Photomicrographs show representative hematoxylin and eosin
(hemorrhage) or fibrin-stained skin sections from Mac-1-deficient
mice injected with either wild-type cells (wt/ Mac-12/2) or triple
knockout cells (H,F,L2/2/ Mac-12/2).
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from integrin-mediated cellular activation in an in vivo in-
flammatory disease. In the vast majority of experimental
inflammation models, the presence of tissue injury usu-
ally correlates with inflammatory (neutrophil) cell infil-
trate into the lesion sites. However, in the LSR model,
this is not the case—all of the mutant mice we have ex-
amined displayed normal neutrophil recruitment into the
disease site independent of vascular injury and hemor-
rhage. We have taken advantage of these aspects of
the LSR model to study the upstream ligands, down-
stream signaling molecules, and effector systems of
neutrophil Mac-1, thereby allowing us to analyze the
contribution of this integrin to cellular activation and
resulting inflammatory tissue injury in vivo. Our studies
indicate that interaction of Mac-1 on neutrophils with
complement iC3b deposits within the vessel wall leads
to an intracellular signaling pathway involving Src-family
and Syk kinases, causing degranulation and vascular
injury that is dependent on release of neutrophil elastase
(Figure 7).
Mice deficient in complement C3, which therefore are
unable to form the Mac-1 ligand iC3b, phenocopied
Mac-1-deficient mice in all aspects of the LSR, consis-
tent with a previous report suggesting suppression of
the LSR after complement depletion (Fong and Good,
1971). This suggests that the interaction of Mac-1 on
neutrophils with complement C3 that is deposited along
the vascular walls at the site of TNF injection promotes
neutrophil activation leading to tissue damage. Comple-
ment may be on the endothelium (Marks et al., 1989)
and/or in the subendothelial matrix, which can fix iC3b
upon its exposure after cytokine-induced endothelial
cell retraction (Hindmarsh and Marks, 1998). Our finding
that restoration of disease in Mac-1-deficient mice re-
quired the intravenous delivery of wild-type neutrophils
suggests that the interaction of Mac-1 on circulating
neutrophils with fixed complement must occur within
the vascular lumen for significant vessel damage to
occur (Figure 7). Previous reports have suggested that
complement deposition in the vasculature is consis-
tently associated with vasculitides (Chen et al., 2002;
Danning et al., 1998; Prins et al., 1996). Mac-1 interaction
with complement C3bi could drive neutrophil degranula-
tion at the vessel wall via a process often referred to as
Table 3. Adoptive Transfer of Syk-Deficient Neutrophils Fails to
Restore Normal Disease Activity in Mac-1-Deficient Mice
Undergoing LSR
Recipient Mac-12/2 (n = 8) Mac-12/2 (n = 8)
Donor Wild-Type or Syk+/2 Syk2/2
Hemorrhage (%) 12.55 6 0.24 0.38 6 0.10*
Fibrin (%) 92.40 6 3.16 6.87 6 0.49*
Neut. Exudate (%) 12.97 6 0.55 9.06 6 0.40
Mac-1-deficient mice (Mac-12/2) primed with LPS were injected
once intravenously with 5 3 106 wild-type/Syk+/2 or Syk-deficient
(Syk2/2) neutrophils just prior to intradermal TNF injection. Neutro-
phils were prepared from fetal liver chimeric mice that had previ-
ously been established with wild-type/Syk+/2 or Syk2/2 cells. Scor-
ing of skin lesions in the adoptively transferred Mac-12/2 tissue
sections for parameters of hemorrhaging, fibrin deposition, and neu-
trophil accumulation was conducted as described in Figure 1. n =
number of mice analyzed to produce the averaged data, *p < 0.05
compared to wild-type/Syk+/2 cohorts.‘‘frustrated phagocytosis,’’ where phagocytes may form
a tight seal around the complement deposits, creating a
compartment into which secreted proteinases can be
concentrated and protected from serum proteinase in-
hibitors, thus maximizing endothelial cell injury (Heiple
et al., 1990; Wright and Silverstein, 1984).
Previous work has shown that treatment with CD18
antibody results in the reduction in LSR-induced
hemorrhagic legions in rabbits (Argenbright and Barton,
1992), although the effect of CD18 blockade on neutro-
phil accumulation was not reported. Neutrophil recruit-
ment in the LSR was essentially normal in Mac-1-defi-
cient, LFA-1-deficient, and ICAM-1-deficient mice.
Thus, it is possible that a combination of LFA-1 and
Mac-1 contributes to neutrophil recruitment in the LSR
model. Indeed, only an ablation of both Mac-1 and
LFA-1 significantly reduced neutrophil accumulation in
Figure 6. Adhesion of Neutrophils to Complement-Coated Surfaces
Leads to Elastase Release in Wild-Type but Not Mac-1- or Hck
Kinase-Deficient Cells
(A) Analysis of adhesion of TNF-stimulated wild-type or Mac-1-defi-
cient (Mac-12/2) neutrophils to wild-type or C3-deficient (C32/2)
fresh mouse serum-coated plates. TNF-stimulated neutrophils
were incubated with plates for 40 min, plates were washed, and
the number of attached neutrophils in three high-power fields was
counted microscopically. Data shown are the average 6 SD of two
independent experiments.
(B) The release of the azurophilic granule marker neutrophil elastase
was assessed after plating of TNF-activated wild-type or Mac-12/2
neutrophils on fresh mouse serum-coated dishes. The data are plot-
ted as % degranulation, which represents the amount of neutrophil
elastase released from 2.53 103 neutrophils per well, divided by the
total cellular elastase activity (determined by lysis of cells in 0.02%
Triton X-100) after 60 min of adhesion to the indicated serum-coated
surface. Data shown are the average 6 SD of two independent
experiments.
(C) Release of neutrophil elastase from wild-type,Mac-12/2,Hck2/2,
Fgr2/2, Lyn2/2, or triple src mutant (H,F,L2/2) neutrophils was con-
ducted as described above. Data shown are the average6 SD. n = 4
to 8 independent experiments for each group except for the first (wt,
Fgr2/2, and Lyn2/2), which is n = 2.
*p < 0.005, **p < 0.05 in comparison to respective wt.
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Activation of the alternative complement pathway occurs continuously in vivo through the C3 ‘‘tick-over’’ pathway. LPS, the ‘‘preparative agent’’
in the Shwartzman reaction, significantly increases C3 synthesis (Colten et al., 1986; Thorbecke et al., 1965), and TNF promotes synthesis and
release of complement components C3 and factor B by endothelial cells, thus leading to further opportunities for local activation of complement
(Kawakami et al., 1997). TNF promotes endothelial cell retraction, with subsequent exposure of the subendothelial extracellular matrix (ECM),
which is a target for C3b/iC3b fixation (Hindmarsh and Marks, 1998). LPS and TNF upregulate adhesion receptors required for neutrophil accu-
mulation. Neutrophils are recruited (in a fashion independent of Mac-1 and complement), allowing Mac-1 (amb2) on the cell surface to bind the
iC3b deposited within the vessel wall. This triggers activation of Src-family and Syk kinases, leading to an intracellular signaling cascade that
results in flattening of the neutrophil against the vessel wall and stimulation of localized degranulation, leading to neutrophil elastase release.
The elastase promotes vascular injury contributing to tissue hemorrhage.a peritonitis model (Lu et al., 1997). Furthermore, since
ICAM-12/2 mice were unaffected, the CD18 integrins
may recognize another endothelial adhesion ligand
such as ICAM-2 or a combination of ICAM-1 and
ICAM-2 to mediate neutrophil influx. On the other
hand, as anti-CD18 mAb injection leads to only a modest
reduction (45%) in cellular accumulation in an LPS-in-
duced hemorrhage model (Zhou et al., 2003), it is possi-
ble that other integrins (b1 or b3) play a more important
role in the adhesive event leading to transmigration of
neutrophils out of the vessels. The chemoattractants re-
sponsible for neutrophil recruitment in the LSR are un-
known. Since C3 deficiency had no effect on neutrophil
accumulation, the C3 cleavage product C3a, as well as
C5a (which are powerful neutrophil chemoattractants),
are not seminal to neutrophil accumulation in the LSR.
Further investigation will be required to dissect the ad-
hesion receptors and chemokine/chemoattractant
pathways that are essential to neutrophil accumulation
in this disease model.
Proteinases and oxygen radical species released from
accumulated neutrophils are potential effectors of ves-
sel injury and thrombosis. Neutrophil-derived oxygen
radicals may promote tissue injury through oxidation
of tryptophan residues or production of bityrosine in ma-
trix molecules (Riedle and Kerjaschki, 1997), by indi-
rectly activating latent collagenase and gelatinase,and/or neutralization of proteinase inhibitors such as
a1 anti-trypsin and secretory leukoprotease inhibitor
(Kawabata et al., 2002). Neutrophils may also directly
modulate blood coagulation through the release of oxy-
gen radicals and proteinases (Bouchard and Tracy,
2001). Our studies demonstrated that NADPH oxidase-
derived reactive oxygen species were not significant
effectors of thrombohemorrhagic vasculopathy in the
LSR. Neutrophils store an arsenal of proteinases in pri-
mary (elastase, cathepsin G, and PR3), secondary
(MMP8, 80% uPA), and tertiary (MMP9, 20% uPA) gran-
ules (Owen and Campbell, 1999) that can promote ves-
sel damage and thrombosis in the LSR (Movat and
Wasi, 1985). Despite a demonstrated role for MMP9 in
mice in several experimentally induced inflammatory
or autoimmune pathologies (Liu et al., 1998; Opdenakker
et al., 2001; Shapiro, 1998) and MMP8 in the inflamma-
tory response induced by carcinogens (Balbin et al.,
2003), these two metalloproteinases played no detect-
able role in tissue injury in our model. In contrast, neutro-
phil elastase, which degrades diverse substrates in vitro
including matrix macromolecules, plasma proteins,
proinflammatory mediators, and adhesion receptors,
was required for lesion development, demonstrating
that release of this enzyme is the primary cause of tissue
injury in the LSR. Moreover, our crosscomplementation
experiments demonstrated that elastase specifically in
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importance specifically of elastase versus other MMPs
for the development of vasculopathy suggests that de-
spite the large number of proteinases that are frequently
coexpressed and their broad substrate specificity in vi-
tro, each enzyme may be restricted to a very specific
function in vivo. Our in vivo analyses suggested that
Mac-1-mediated release of elastase is important in the
development of disease. While we believe that the de-
velopment of hemorrhagic lesions is due mainly to
Mac-1-dependent signaling leading to elastase release,
it is also possible that Mac-1 contributes to disease
pathogenesis by directly retaining elastase on the neu-
trophil surface (Cai and Wright, 1996) and thereby con-
centrating its proteolytic activity (Owen and Campbell,
1999).
The downstream signaling reactions after leukocyte
integrin engagement have been well studied with cell-
based assay methods (Berton et al., 2005; Lowell,
2004). Engagement of Mac-1 leads to activation of Src-
family and Syk kinases, which in turn signal to down-
stream molecules such as SLP-76 and the Vav-family
exchange factors. Activation of this signaling pathway
leads to degranulation and respiratory burst in neutro-
phils. The critical role of these signaling molecules has
been defined by examination of neutrophil functional
responses in vitro by means of cells isolated from the
respective knockout mice (Gakidis et al., 2004; Lowell,
2004; Newbrough et al., 2003). However, there have
been very few studies of the functional roles of these sig-
naling molecules in in vivo disease models that reflect
integrin function. Mice lacking both Hck and Fgr have re-
duced mortality and tissue damage in a systemic endo-
toxin model, which correlates with reduced neutrophil
accumulation in the liver parenchyma (Lowell and Ber-
ton, 1998). Similarly, Fgr2/2 mice have reduced eosino-
phil accumulation during allergic pneumonitis (Vicentini
et al., 2002). There are no reports of the contribution of
Syk kinase in an in vivo disease model. Our results illumi-
nate the central role of this kinase and the overlapping
roles of Src-family kinases in a Mac-1-dependent in-
flammatory injury model (Figure 7), thus validating the
physiologic significance of prior in vitro cell-based
experiments.
Previous studies indicate a largely redundant role for
the Src-family kinases downstream of integrin ligation.
This is especially true for Hck versus Fgr—no unique
functional role for these kinases has been defined in
cell-based experiments. Thus, the dominant role for
the Hck kinase in the primary granule release response
after complement binding by neutrophils, which corre-
lated with the reduced disease in the LSR observed in
the Hck2/2 mice, is one of the few examples available
demonstrating the functional importance of a specific
Src-family kinase in leukocyte function. Hck has been
localized to primary granules and has been shown to
translocate to the phagosomal membrane after serum-
opsonized zymosan phagocytosis (Mohn et al., 1995),
consistent with a major functional role in primary granule
mobilization in neutrophils.
By using a genetic approach and adoptive neutrophil
transfer methods, we have defined a signaling pathway
beginning with Mac-1 recognition of fixed complement,
leading to activation of Src-family and Syk kinases thatin turn stimulate neutrophil activation in which release
of a specific proteinase (NE) is responsible for the hem-
orrhagic vasculitis in the Shwartzmann reaction (Fig-
ure 7). Integrin signaling leading to activation of neutro-
phil effector function has been postulated to contribute
to tissue injury during inflammation. However, in the ma-
jority of disease models, it is difficult to validate a role for
integrins in leukocyte activation independent of their
role in cellular recruitment. The mechanism of the path-
ophysiology in the LSR has allowed us to separate these
integrin functions and demonstrate a clear role for integ-
rin signaling through nonreceptor tyrosine kinases to
leukocyte activation in an in vivo disease model. The ob-
vious implication of these studies is that inhibitors di-
rected against the signaling molecules downstream of
Mac-1 will provide novel therapeutic approaches to
the treatment of vasculitis and potentially other inflam-
matory disease states.
Experimental Procedures
Reagents and Antibodies
Recombinant murine TNF was from R&D systems (Minneapolis,
MN). Escherichia coli LPS 055:B5 was from Sigma (St. Louis, MO).
These studies were conducted with LPS that had high endotoxin
activity (1,500,000 endotoxin units/mg) and low protein contamina-
tion (1.4%) according to manufacturer’s certificate of analysis. Rab-
bit anti-human fibrinogen and rabbit anti-human C3 complement
were from DAKO (Carpinteria, CA).
Mice
Gene-deleted mice backcrossed to C57Bl/6 are denoted as B6 with
a F# designating the number of generations the animals were back-
crossed to C57Bl/6. The gene nomenclature in mice is given in pa-
rentheses. gp91phox2/2 (Cybb) mice B6F12 and LFA-1-deficient
(Itgal) mice B6F12 were purchased from Jackson Laboratory (Bar
Harbor, ME). Mac-1-deficient (Itgam) mice (Coxon et al., 1996) are
B6F9 and were bred and maintained in the Viral Antigen Free facility
at the Longwood Medical Research Center (LMRC) animal housing
facility at Harvard Medical School. ICAM-1-deficient (Icam1) mice
(Xu et al., 1994) B6F7 were bred and maintained at the CBR Institute
of Biomedical Research, Harvard Medical School (Boston, MA).
Complement C3-deficient (C3) (Wessels et al., 1995) mice B6F10
were generously provided by Dr. Michael C. Carroll (CBR Institute
of Biomedical Research). Neutrophil elastase-deficient (Ela2) mice
(Belaaouaj et al., 1998) were B6F10. Hck2/2 (Hck), Fgr2/2 (Fgr),
Lyn2/2 (Lyn), and triple src-deficient Hck,Fgr,Lyn2/2 mice were all
B6F15 and maintained in the SPF facility at UCSF. Syk2/2 (Syk)
B6F6 heterozygous mice were used for production of Syk2/2 fetal
liver stem cells used for reconstitution of lethally irradiated B6 recip-
ients, to generate Syk2/2 fetal liver chimeras as described (Mocsai
et al., 2002). Age-matched wild-type C57Bl/6 mice were used for
all the aforementioned C57Bl/6 gene-deleted animals and were
bred in the LMRC facility or purchased from Jackson Laboratory.
For Syk2/2 fetal liver chimeras, sibling fetal liver cells from either
wild-type or Syk+/2 mice were used to generate control chimeras.
Syk2/2 versus wild-type or heterozygous fetal animals were deter-
mined by visual inspection (the Syk2/2 fetus has an obvious bleed-
ing/edema phenotype), and fetal liver was used immediately for
transfer to irradiated recipients without separately identifying wild-
type versus Syk+/2 cells. Neutrophil elastase-deficient mice and
mice deficient in MMP8 (Mmp8) (C57Bl/6/129Sv mixed strain) (Bal-
bin et al., 2003) or MMP9 (Mmp9) (pure 129Sv) (Vu et al., 1998) or
mice deficient in both MMP8 and MMP9 were bred in the Viral Anti-
gen Free facility at Harvard School of Public Health animal housing
facility and maintained in the LMRC facility. Age-matched wild-
type controls for MMP8- and MMP9-deficient mice were C57/129
strain (B6129F1, hybrid) and pure 129Sv/Ev strain (129S6/SvEv, in-
bred), respectively, and were purchased from Taconic. Experimental
procedures were approved by the Animal Care and Use Committee
of Harvard Medical School.
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8- to 12-week-old age-matched male mice were primed on day 0 by
a subcutaneous injection of Escherichia coli LPS 055:B5 at 100 mg/
mouse in 0.1 ml of sterile PBS with a 30G 1/2 gauge needle (Becton
Dickinson). 24 hr later (day 1), recombinant murine TNF (R&D) at 0.3
mg/mouse was injected at the same site (Subramaniam et al., 1996).
On day 2, the skin was excised and evaluated for MPO activity and/
or paraffin sections were made. Hematoxylin and eosin (HE)-stained
paraffin sections were prepared, and the degree of inflammatory cell
infiltration, thrombus formation, and fibrin deposition as well as
hemorrhage were scored microscopically, as described below
(Grading of Lesions).
In some experiments, skin air pouches were generated prior to the
induction of the LSR. 4 ml of air was injected under the dorsal skin of
mice followed by an additional injection of air on day 3. After 7 days,
LPS was instilled in the air pouch, followed 24 hr later by injection of
TNF. After an additional 24 hr, the air pouch was lavaged with 3 ml
ice-cold PBS. Equal amount of lavage fluid containing the same
number of cells from mice were assayed for elastase release.
Grading of Lesions
Morphometric Analysis
The skin was excised and paraffin sections were made for micro-
scopic grading of lesions. The sections were hematoxylin and eosin
(HE) stained to assess hemorrhaging and the percentage of morpho-
logically intact vessels that were occluded by thrombi. A specific
esterase stain described below identified neutrophils, and fibrin de-
position was assessed by fibrin/fibrinogen immunostaining. Quanti-
fication of hemorrhaging and neutrophil accumulation were done as
follows and reported as the percent of total events. For a hemorrhage
score, four consecutive fields from the HE-stained sections were ob-
tained at 403 magnification and digitized as JPEG images with QI-
maging QCapture Software (Quantitative Imaging Corp., Burnaby,
BC, Canada). The stored digital images were analyzed by Image-
Pro Plus software (Media Cybernetics, Silver Spring, MD), in which
the specified color was extracted and total area was measured.
The red signal in H&E-stained sections indicated red blood cells
and the extracted signal inside vessels was excluded. The blue sig-
nal in esterase-stained sections indicated neutrophils. The darker
blue, large cells were mast cells and were excluded. The score for
each of these was given as a percentage and calculated as follows:
red or blue signal divided by the total measured area. Sections were
immunostained with antibody to fibrin to assess fibrin localization in
the sections, and the percentage of morphologically intact vessels
in the entire section with fibrin staining outside the vessel wall was
determined.
Neutrophil Enumeration
Chloroacetate Esterase Reaction. Paraffin sections from the
Shwartzman lesion site were deparaffinized and incubated in freshly
prepared chloroacetate solution containing 0.0125% Naphesol
AS-D (Sigma) and 0.0625% Fast Blue BB salt (Sigma) in phosphate
buffer (pH 7.3) for 1.5 hr in the dark. Neutrophils were enumerated
on digitized images as described in the previous section.
Myeloperoxidase Assay. Skin samples were excised, weighed,
and homogenized in 10% hexadecyltrimethylammonium bromide
in 50 mM phosphate buffer (pH 6.0). The samples were centrifuged
and the supernatant was assayed for MPO activity with a chromogen
(o-dianisidine HCl) as previously described (Bradley et al., 1982). The
relative MPO activity was converted to neutrophil content in tissues
via a standard curve generated with defined numbers of bone mar-
row-derived murine neutrophils.
Immunohistochemistry
For fibrin staining, paraffin sections from the Shwartzman lesion site
were deparaffinized, sequentially blocked with avidin D solution and
biotin blocking solution (Vector Laboratories), and stained with
a rabbit anti-human fibrinogen (1:1000 dilution; Dako), which cross-
reacts with mouse fibrin/fibrinogen. Sections were then treated with
a biotinylated goat anti-rabbit antibody (Vector Laboratories) and
developed with DAB substrate kit for horseradish peroxidase
(Vector Laboratories). Immunostaining for complement C3 was con-
ducted as previously reported with some modification (Sinclair et al.,
1981). In brief, 7 mm deparaffinized/hydrated paraffin sections were
treated with 0.1% trypsin (Sigma) for 30 min at 37C to unmask
antigen. The sections were incubated with rabbit anti-human C3complement at 1:100. Staining was visualized by microscopy at
403.
Ribonuclease Protection Assay
Snap-frozen skin samples from the Shwartzman lesion were homog-
enized in TRIzol reagent (Life Technologies, Gaithersburg, MD) with
a Dounce-type homogenizer. Total RNA was then subjected to a
multiprobe RPA system (BD Biosciences, San Diego, CA) with the
mCK-2b DNA template set according to the manufacturer’s instruc-
tions. Protected fragments were resolved in a 6% polyacrylamide-
urea gel. The dried gels were developed with a phosphorimager
(Molecular Dynamics, Sunnyvale, CA), and bands were quantitated
with NIH image. Within each sample, the density of each specific
mRNA transcript was divided by that of the glyceraldehyde phos-
phate dehydrogenase (GAPDH) band.
Neutrophil Adoptive Transfers
Murine neutrophils were collected from two femurs by washing out
the bone marrow with 1 ml of ice-cold RPMI with 5% FCS followed
by NH4Cl lysis. Neutrophils were isolated from the cell suspension
by density gradient centrifugation on Percoll (Sigma) with stepwise
gradients of 55%, 65%, and 75% Percoll. After centrifugation at
1600 rpm for 30 min at 4C without the brake, the band between
65% and 75% of Percoll was collected. Cells (>95% neutrophils)
were then washed and suspended in HBSS without Ca2+/Mg2+ sup-
plemented with 0.25 mM HEPES (pH 7.4), at a concentration of 2.53
107 cells/ml. 53 106 cells in 200 ml HBSS without Ca2+/Mg2+ were in-
jected into mice via tail vein 2 hr prior to TNF injection. Assuming
a blood volume of 2.2 ml per mouse, the heterologous neutrophils
are present at a concentration of approximately 2.3 3 106 neutro-
phils per ml of blood. The circulating neutrophil count of a wild-
type C57Bl/6 mouse averaged 2.5 3 106 neutrophils per ml. Thus,
the reconstituted neutrophils are introduced into mice, on average,
at a 1:1 ratio with the endogenous circulating neutrophils.
Neutrophil Adhesion Assay
Fresh mouse serum mixed at equal volume with DPBS (PBS plus
Ca2+ and Mg2+) was placed in 24-well plates and incubated at
37C for 1 hr. The plates were washed with PBS and blocked with
1% PVP (Polyvinylpyrrolidone, Sigma) at room temperature for 1
hr and washed extensively with PBS at 37C for 40 min. 2.5 3 105
neutrophils in 500 ml of DPBS, pretreated with rmTNF (50 ng/ml at
37C for 15 min), were added to the wells for 40 min, and then the
plates were washed gently three times with prewarmed PBS. The re-
maining adherent cells in three microscopic fields at 403magnifica-
tion were quantified.
Primary Granule Release Assay
Elastase release was analyzed with a real-time fluorimetric assay as
previously described (Sklar et al., 1982). In brief, 2.5 3 105 neutro-
phils in 500 ml DPBS pretreated with TNF were added to 24-well
plates coated with fresh mouse serum as described above in the
presence of 100 ml 20 mM elastase substrate peptide N-methoxysuc-
cinyl-Ala-Ala-Pro-Val-7-amido-4-methylcoumarin (Sigma). The fluo-
rescence of the samples was measured at 380 nm excitation and 460
nm emission with a Spectra Max spectrofluorimeter (Molecular De-
vices, Sunnyvale, CA) at 2 min intervals over a period of 60 min total.
Elastase activity was calculated as being proportional to the instan-
taneous slope of the increase in the fluorescence of the reaction
product 7 amino 4-methylcoumarin. The percent release of elastase
was calculated by dividing the elastase activity by the total cellular
elastase activity as measured by lysing cells in the well with 0.02%
Triton-X100 at the end of the run. For analysis of neutrophils and la-
vage fluid retrieved from the air pouch of mice, equal number of cells
in lavage fluid were evaluated.
Statistical Analysis
All data are expressed as means6 standard error of the mean (SEM)
for data resulting from in vivo analyses of mice and 6 standard de-
viation (SD) for data derived from in vitro assays on isolated murine
neutrophils. In all cases, an unpaired t test was used to compare two
groups. Significance was set at p < 0.05.
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